These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Bosio CM; Moore BD; Warfield KL; Ruthel G; Mohamadzadeh M; Aman MJ; Bavari S Virology; 2004 Sep; 326(2):280-7. PubMed ID: 15302213 [TBL] [Abstract][Full Text] [Related]
6. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease. Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648 [TBL] [Abstract][Full Text] [Related]
7. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. Colonna M; Facchetti F J Infect Dis; 2003 Jun; 187 Suppl 2():S397-401. PubMed ID: 12792857 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. Bouchon A; Dietrich J; Colonna M J Immunol; 2000 May; 164(10):4991-5. PubMed ID: 10799849 [TBL] [Abstract][Full Text] [Related]
9. Potential factors induced by filoviruses that lead to immune supression. Mohamadzadeh M Curr Mol Med; 2009 Mar; 9(2):174-85. PubMed ID: 19275625 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243 [TBL] [Abstract][Full Text] [Related]
14. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522 [TBL] [Abstract][Full Text] [Related]
15. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. Valmas C; Grosch MN; Schümann M; Olejnik J; Martinez O; Best SM; Krähling V; Basler CF; Mühlberger E PLoS Pathog; 2010 Jan; 6(1):e1000721. PubMed ID: 20084112 [TBL] [Abstract][Full Text] [Related]
16. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. Radsak MP; Salih HR; Rammensee HG; Schild H J Immunol; 2004 Apr; 172(8):4956-63. PubMed ID: 15067076 [TBL] [Abstract][Full Text] [Related]
17. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650 [TBL] [Abstract][Full Text] [Related]
18. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy]. Stock I Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746 [TBL] [Abstract][Full Text] [Related]
19. Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays. Kamata T; Natesan M; Warfield K; Aman MJ; Ulrich RG Clin Vaccine Immunol; 2014 Dec; 21(12):1605-12. PubMed ID: 25230936 [TBL] [Abstract][Full Text] [Related]
20. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system. Guito JC; Albariño CG; Chakrabarti AK; Towner JS Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]